Suppr超能文献

[睾酮与勃起功能障碍]

[Testosterone and erectile dysfunction].

作者信息

Diemer T

机构信息

Klinik und Poliklinik für Urologie, Kinderurologie und Andrologie, Universitätsklinikum Giessen und Marburg GmbH, Standort Giessen.

出版信息

Urologe A. 2010 Jan;49(1):26-31. doi: 10.1007/s00120-009-2202-2.

Abstract

Primary hypogonadism represents a classic but rare cause of erectile dysfunction (ED) in men. Therapy with testosterone as monotherapy is therefore unlikely to cure ED in the typical ED patient. However, recent developments indicate a much greater role of testosterone in erectile function than has been supposed in the past. Serum testosterone levels decline in men with increasing age. Aging men might develop late-onset hypogonadism (LOH) associated with characteristic symptoms. Typical symptoms of LOH are represented by decreased libido and sexual function, osteoporosis, altered distribution of body fat, overall reduction in physical strength, and alterations in the general mood. Experimental and clinical studies over the last few years have also pointed out that hypogonadism results in characteristic alterations of the erectile tissue of the penis. These alterations might be reversible in response to hormone therapy with testosterone. Particularly testosterone might be a helpful supportive therapy in cases where PDE-5 antagonists have tended to lose their effectiveness on the erectile tissue in the treatment of ED.

摘要

原发性性腺功能减退是男性勃起功能障碍(ED)的一个典型但罕见的病因。因此,对于典型的ED患者,仅用睾酮进行治疗不太可能治愈ED。然而,最近的研究进展表明,睾酮在勃起功能中所起的作用比过去所认为的要大得多。男性血清睾酮水平会随着年龄增长而下降。老年男性可能会出现与特征性症状相关的迟发性性腺功能减退(LOH)。LOH的典型症状包括性欲和性功能减退、骨质疏松、体脂分布改变、体力整体下降以及情绪变化。过去几年的实验和临床研究还指出,性腺功能减退会导致阴茎勃起组织发生特征性改变。这些改变可能会随着睾酮激素治疗而逆转。特别是在ED治疗中,当5型磷酸二酯酶(PDE-5)拮抗剂对勃起组织失去疗效时,睾酮可能是一种有效的辅助治疗方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验